 | Up a level |
Hoffmann, Lone; Mortensen, Hanna; Shamshad, Muhammad; Berbee, Maaike; Bizzocchi, Nicola; Bütof, Rebecca; Canters, Richard; Defraene, Gilles; Ehmsen, Mai Lykkegaard; Fiorini, Francesca; Haustermans, Karin; Hulley, Ryan; Korevaar, Erik W; Clarke, Matthew; Makocki, Sebastian; Muijs, Christina T; Murray, Luke; Nicholas, Owen; Nordsmark, Marianne; Radhakrishna, Ganesh; ... (2022). Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: Results from eight European centres. Radiotherapy and oncology, 172, pp. 32-41. Elsevier 10.1016/j.radonc.2022.04.029
Tambas, Makbule; van der Laan, Hans Paul; Steenbakkers, Roel J H M; Doyen, Jerome; Timmermann, Beate; Orlandi, Ester; Hoyer, Morten; Haustermans, Karin; Georg, Petra; Burnet, Neil G; Gregoire, Vincent; Calugaru, Valentin; Troost, Esther G C; Hoebers, Frank; Calvo, Felipe A; Widder, Joachim; Eberle, Fabian; van Vulpen, Marco; Maingon, Philippe; Skóra, Tomasz; ... (2022). Current practice in proton therapy delivery in adult cancer patients across Europe. Radiotherapy and oncology, 167, pp. 7-13. Elsevier 10.1016/j.radonc.2021.12.004
Langendijk, Johannes A; Troost, Esther G C; Haustermans, Karin; Grau, Cai; Weber, Damien Charles (2019). Reply to Laprie A. et al. Radiotherapy and oncology, 130, p. 194. Elsevier 10.1016/j.radonc.2018.10.008
Langendijk, Johannes A; Orecchia, Roberto; Haustermans, Karin; Zips, Daniel; Balosso, Jacques; Lacombe, Denis; Lievens, Yolande; Weber, Damien Charles; Grau, Cai; Troost, Esther G C (2018). Prospective data registration and clinical trials for particle therapy in Europe. Radiotherapy and oncology, 128(1), pp. 9-13. Elsevier 10.1016/j.radonc.2018.06.001
Tosco, Lorenzo; Laenen, Annouschka; Briganti, Alberto; Gontero, Paolo; Karnes, R Jeffrey; Bastian, Patrick J; Chlosta, Piotr; Claessens, Frank; Chun, Felix K; Everaerts, Wouter; Gratzke, Christian; Albersen, Maarten; Graefen, Markus; Kneitz, Burkhard; Marchioro, Giansilvio; Salas, Rafael Sanchez; Tombal, Bertrand; Van den Broeck, Thomas; Van Der Poel, Henk; Walz, Jochen; ... (2018). The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis. European urology focus, 4(3), pp. 369-375. Elsevier 10.1016/j.euf.2016.12.008
Moris, Lisa; Van den Broeck, Thomas; Tosco, Lorenzo; Van Baelen, Anthony; Gontero, Paolo; Karnes, Robert Jeffrey; Everaerts, Wouter; Albersen, Maarten; Bastian, Patrick J; Chlosta, Piotr; Claessens, Frank; Chun, Felix K; Graefen, Markus; Gratzke, Christian; Kneitz, Burkhard; Marchioro, Giansilvio; Salas, Rafael Sanchez; Tombal, Bertrand; Van Der Poel, Henk; Walz, Jochen Christoph; ... (2016). Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection. Frontiers in Surgery, 3, p. 65. Frontiers 10.3389/fsurg.2016.00065
Litovkin, Kirill; Van Eynde, Aleyde; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Thomas; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Gramme, Pierre; Helleputte, Thibault; Isebaert, Sofie; Haustermans, Karin; Bollen, Mathieu (2015). DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer. PLoS ONE, 10(6), e0130651. Public Library of Science 10.1371/journal.pone.0130651
Litovkin, Kirill; Joniau, Steven; Lerut, Evelyne; Laenen, Annouschka; Gevaert, Olivier; Spahn, Martin; Kneitz, Burkhard; Isebaert, Sofie; Haustermans, Karin; Beullens, Monique; Van Eynde, Aleyde; Bollen, Mathieu (2014). Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. Journal of cancer research and clinical oncology, 140(11), pp. 1849-1861. Springer 10.1007/s00432-014-1738-8
Joniau, Steven; Van den Bergh, Laura; Peeters, Charlotte; Haustermans, Karin; Spahn, Martin (2012). Nodal staging in prostate cancer: still an unresolved issue. European urology, 61(6), pp. 1139-41. Amsterdam: Elsevier 10.1016/j.eururo.2011.12.044
